To date, in vivo studies prove that allicin supplementation improves cognitive function while reducing Aβ expression and accumulation in various preclinical AD models, including aluminum chloride-treated rats, APP/PS1 mice, and Aβ1–42 treated mice [473,474,475,476]. Here, APP is linked to Alzheimer disease.